ZLDI-8 | m-entrepreneurship.com

Product Name :
ZLDI-8

Search keywords :
ZLDI-8

drugId :
null

Target Vo:
Disintegrin and metalloproteinase domain-containing protein 17

Target Vo Short Name :
ADAM17

Moa_Name:
Disintegrin and metalloproteinase domain-containing protein 17 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shenyang Pharmaceutical University

Active Company_Name :
Shenyang Pharmaceutical University

Active Indication_Name:
Carcinoma, Hepatocellular

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Arginase-1 Antibody
SOX9 Antibody
KLF4 Antibody (YA716): KLF4 Antibody (YA716) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to KLF4 (3B3). It can be used for WB assays with tag free, in the background of Transfected.

Author: Betaine hydrochloride

Related Posts